Skip to main content
Year archive

Anuh Pharma Ltd. — 2023 filings

All 52 regulatory filings released by Anuh Pharma Ltd. (ANUHPHR) in 2023, sourced directly from the official regulator.

52 Filings
2023 Period
2023 filings (52)
Filing Released Lang
Closure of Trading Window for the quarter ended 31st December, 2023.
Regulatory Filings
2023-12-29 English
Disclosure under Regulation 30 of LODR.
Regulatory Filings
2023-12-13 English
Scrutizer Report on Postal Ballot.
Regulatory Filings
2023-12-12 English
Postal Ballot Intimation.
Regulatory Filings
2023-11-10 English
Financial Results for the quarter ended 30th September, 2023
Regulatory Filings
2023-11-10 English
Outcome of Board Meeting dated 10th November, 2023
Regulatory Filings
2023-11-10 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve 1) To consider and approve Unaudited ....
Regulatory Filings
2023-11-02 English
Approval Received for Reclassification of shares from promoter/promoter Group to Public Category.
Regulatory Filings
2023-10-19 English
Compliance Certificate Under Reg 74 (5) of SEBI (DP) Regulations for the quarter ended 30th September, 2023.
Regulatory Filings
2023-10-11 English
Closure of Trading Window for the Quarter Ended 30th September, 2023.
Regulatory Filings
2023-09-29 English
Loss of Share Certificate.
Regulatory Filings
2023-09-13 English
Submission of Scrutinizer Report.
Regulatory Filings
2023-08-22 English
Submission of Voting Results Under Regulation 44 of LODR.
Regulatory Filings
2023-08-22 English
Investor Presentation for the Q1-2024.
Regulatory Filings
2023-08-21 English
Intimation under Regulation 30 of the SEBI (LODR)- Appointment/Reappointment of Directors.
Regulatory Filings
2023-08-19 English
Proceedings of the 63rd Annual General Meeting of the Shareholders of the Company
Regulatory Filings
2023-08-19 English
Results-Financial Results for June 30,2023.
Regulatory Filings
2023-08-11 English
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as ....
Regulatory Filings
2023-08-11 English
Disclosure of Events/Information - Approval from EDQM for CEP of Gliclazide API which is an Anti-Diabetic Drug.
Regulatory Filings
2023-08-11 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve 1) To consider and approve Unaudited ....
Regulatory Filings
2023-08-03 English
Reg. 34 (1) Annual Report.
Regulatory Filings
2023-07-25 English
Fixes Record Date For Dividend and Annual General Meeting.
Regulatory Filings
2023-07-25 English
Fixes Book Closure For Annual General Meeting
Regulatory Filings
2023-07-25 English
Announcement under Regulation 30 (LODR)-Updates
Regulatory Filings
2023-07-24 English
General-Updates
Regulatory Filings
2023-07-23 English
Disclosure of Event/Information-Approval from EDQM for CEP of Azithromycin API.
Regulatory Filings
2023-07-13 English
Certificate Under Regulation 74 (5) for the Quarter Ended 30th June, 2023
Regulatory Filings
2023-07-10 English
Intimation of Trading Window Closure as per SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings
2023-06-30 English
Reply to your email dated 16th June, 2023 on clarification on Price Movement`
Regulatory Filings
2023-06-23 English
Dear Sir/Madam, We are enclosing herewith our Company's Investor Presentation for the month of June, 2023. Kindly take the same on record.
Regulatory Filings
2023-06-03 English
Submission of Annual Secretarial Compliance Report for Financial Year ended 31/03/2023
Regulatory Filings
2023-05-24 English
Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Change in Director.
Regulatory Filings
2023-05-20 English
Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Change in Director.
Regulatory Filings
2023-05-20 English
Results-Financial Results for March 31, 2023.
Regulatory Filings
2023-05-19 English
Outcome of Board Meeting dated 19th May, 2023
Regulatory Filings
2023-05-19 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 ,inter alia, to consider and approve 1) To consider and approve Audited ....
Regulatory Filings
2023-05-11 English
Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 for the year ended 31st March, 2023.
Regulatory Filings
2023-05-04 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-28 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-28 English
Please find enclosed the Compliance Certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-04-14 English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended 31st March, 2023
Regulatory Filings
2023-04-11 English
Intimation of Trading Window Closure as per SEBI (Prohibition of Insider Trading) Regulations, 2015 for the quarter and year ended March 31, 2023.
Regulatory Filings
2023-03-31 English
Investor Presentation - Q3 FY2023 Dear Sir/Madam, We are enclosing herewith our Company's Investor Presentation for Q3 FY2023. Kindly take the same on record. Thanking you,
Regulatory Filings
2023-02-17 English
Newspaper Publication of Unaudited Financial Results for the quarter ended 31.12.2022 Please find enclosed herewith the copy of newspaper advertisement with respect to the Unaudited Financial ....
Regulatory Filings
2023-02-17 English
Pursuant to Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) 2015, this is to inform you that Mr. Lalitkumar P Shah (DIN: 00396345) Non-Executive Director of the ....
Regulatory Filings
2023-02-10 English
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing ....
Regulatory Filings
2023-02-10 English
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as ....
Regulatory Filings
2023-02-10 English
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve Pursuant to the provisions of ....
Regulatory Filings
2023-02-03 English
Newspaper Advertisement for transfer of equity shares to Investor Education and Protection Fund ("IEPF") Authority.
Regulatory Filings
2023-01-23 English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended 31st December, 2022.
Regulatory Filings
2023-01-12 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2023-01-07 English
Outcome of Board Meeting dated 6th January, 2023.
Regulatory Filings
2023-01-06 English